BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totaling 1,000 shares, a growth of ∞ from the July 15th total of 0 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 7,702 shares, the short-interest ratio is currently 0.1 days.
BioForce Nanosciences Stock Performance
BioForce Nanosciences stock opened at $3.40 on Monday. The stock has a market cap of $114.07 million, a P/E ratio of 340.34 and a beta of -0.52. BioForce Nanosciences has a fifty-two week low of $0.18 and a fifty-two week high of $3.40. The firm’s fifty day moving average price is $1.72 and its 200-day moving average price is $1.00.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter.
BioForce Nanosciences Company Profile
BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.
The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.
See Also
- Five stocks we like better than BioForce Nanosciences
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
